This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Despite considerable advances to reduce the burden of stroke and other cardiovascular diseases, these remain major causes of morbidity and mortality at the population level. Guidelines have delineated contributory causes for both stroke and coronary artery disease and have identified avenues for prevention.1,2 However, in spite of the clear need to improve preventive efforts, many challenges remain for tackling the complexities of stroke prevention.3 Illustrating this concept, in this issue of Neurology®, Boehme et al.4 report disappointing levels of primary and secondary stroke prevention in a large regional cohort of patients with stroke. Even with easy access to and coverage for health care, 80% of people diagnosed with ischemic stroke had at least 1 untreated or inadequately treated medical risk factor (e.g., hypertension, hyperlipidemia, atrial fibrillation). Fully 95% had an inadequately addressed medical risk factor or lifestyle risk factor (smoking, overweight or obesity, excess alcohol use).
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 995
- © 2019 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham